Drug intelligence / Profile preview

anti-β1-integrin antibody

Development stage
Unknown
Modality
Monoclonal Antibodies → Antibody-Based Therapeutics
01

Overview

An anti-β1-integrin antibody is a monoclonal antibody designed to target and block integrin beta-1 (ITGB1, also known as CD29). Integrin beta-1 is a cell surface receptor that associates with various alpha integrin subunits to form heterodimers that mediate cell-matrix adhesion and signaling. In oncology, blocking integrin beta-1 can disrupt tumor microenvironment interactions, overcome therapy resistance, and inhibit tumor growth and angiogenesis. In research settings, anti-β1-integrin antibodies are widely used to study cell spreading, migration, and signaling pathways, such as the interaction between beta-cells and extracellular matrix components like laminin-5.

Other names
anti-CD29 antibodyanti-CD-29 antibodyanti-CD 29 antibodyanti-beta-1-integrin antibodyanti-beta1-integrin antibodyanti-beta 1-integrin antibodyanti-integrin beta-1 antibodyintegrin beta-1 antibody
02

Targets

ITGB1 (Integrin beta-1)

Beyond the preview

Go deeper on anti-β1-integrin antibody.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on anti-β1-integrin antibody.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call